Dextrose And Electrolyte No. 48 Injection
NDC Package 0338-0143-03

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Dextrose And Electrolyte No. 48 (sodium lactate, potassium chloride, magnesium chloride, monobasic potassium phosphate, sodium chloride and dextrose monohydrate) injection is 5% Dextrose and Electrolyte No. This formulation utilizes a injection delivery system. Marketed by Baxter Healthcare Company, this product is identified by NDC 0338-0143 and is authorized under FDA application NDA017484.

Identification & Billing

NDC Package Code
0338-0143-03
Package Description
500 mL in 1 BAG
Product Code
0338-0143
11-Digit Billing Format
00338014303
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
Units Per Package
500 ML
RxNorm Crosswalk
  • RxCUI: 807396 - glucose 50 MG/mL / magnesium chloride 0.003 MEQ/mL / monobasic potassium phosphate 0.00147 MEQ/mL / potassium chloride 0.0189 MEQ/mL / sodium chloride 0.002 MEQ/mL / sodium lactate 0.0232 MEQ/mL Injectable Solution
  • RxCUI: 807396 - glucose 50 MG/ML / magnesium chloride 0.003 MEQ/ML / monobasic potassium phosphate 0.00147 MEQ/ML / potassium chloride 0.0189 MEQ/ML / sodium chloride 0.002 MEQ/ML / sodium lactate 0.0232 MEQ/ML Injectable Solution
  • RxCUI: 807396 - Glucose 50 MG/ML / Magnesium Chloride 0.003 MEQ/ML / Monobasic K+ phosphate 0.00147 MEQ/ML / K+ Chloride 0.0189 MEQ/ML / NaCl 0.002 MEQ/ML / Sodium Lactate 0.0232 MEQ/ML Injectable Solution
  • RxCUI: 807396 - Glucose 50 MG/ML / Magnesium Chloride 0.003 MEQ/ML / Monobasic Pot phosphate 0.00147 MEQ/ML / Pot Chloride 0.0189 MEQ/ML / NaCl 0.002 MEQ/ML / Sodium Lactate 0.0232 MEQ/ML Injectable Solution

Clinical Specifications

Proprietary Name
Dextrose And Electrolyte No. 48
Non-Proprietary Name
Sodium Lactate, Potassium Chloride, Magnesium Chloride, Monobasic Potassium Phosphate, Sodium Chloride And Dextrose Monohydrate
Substance Name
Dextrose Monohydrate; Magnesium Chloride; Potassium Chloride; Potassium Phosphate, Monobasic; Sodium Chloride; Sodium Lactate
Dosage Form
Injection - A sterile preparation intended for parenteral use; five distinct classes of injections exist as defined by the USP.
Administration Route
Intravenous - Administration within or into a vein or veins.
Active Ingredient(s)
Pharmacologic Class
Usage Information
5% Dextrose and Electrolyte No. 48 Injection (Multiple Electrolytes and Dextrose Injection, Type 1, USP) is indicated as a source of water, electrolytes, and calories or as an alkalinizing agent.

Regulatory & Marketing

Labeler Name
Baxter Healthcare Company
Product Type
Human Prescription Drug
FDA Application #
NDA017484
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
02-02-1979
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0338-0143-03 identifies a specific commercial package of 500 ml in 1 bag of Dextrose And Electrolyte No. 48, a human prescription drug labeled by Baxter Healthcare Company. This product is billed per "ML" milliliter and contains an estimated amount of 500 billable units per package. This injection is formulated for intravenous use and contains dextrose monohydrate; magnesium chloride; potassium chloride; potassium phosphate, monobasic; sodium chloride; sodium lactate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Baxter Healthcare Company on February 02, 1979. The current certification is valid through December 31, 2026.

How is this Baxter Healthcare Company product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00338014303. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 500 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0338-0143-03
11-Digit CMS (5-4-2)
00338-0143-03

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.